10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
July 31, 1999
Primary Completion Date
June 30, 2002
Study Completion Date
June 30, 2002
Conditions
Lung Cancer
Interventions
DRUG
pralatrexate
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00004238 - 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter